Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aurisco Pharmaceutical CoSHSE:605116 -1.88%78 Days Inventory is 328.53 as of Mar. 2026, which is 20% above its 10-year median of 274.65. GuruFocus rates SHSE:605116 with a GF Score™ of 78/100 and a GF Value™ of ¥28.94 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Aurisco Pharmaceutical Co ranks worse than 70.85% on this metric.
The historical rank and industry rank for Aurisco Pharmaceutical Co's Days Inventory or its related term are showing as below:
SHSE:605116'
s Days Inventory Range Over the Past 10 Years
Min: 229.24 Med: 274.65 Max: 329.1
Current: 324.6
During the past 10 years, Aurisco Pharmaceutical Co's highest Days Inventory was 329.10. The lowest was 229.24. And the median was 274.65.
SHSE:605116's Days Inventory is ranked worse than 70.85% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:605116: 324.60
Inventory Turnover measures how fast the company turns over its inventory within a year.
Aurisco Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.28.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aurisco Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.68.
Aurisco Pharmaceutical Co (SHSE:605116) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aurisco Pharmaceutical Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aurisco Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Aurisco Pharmaceutical Co Days Inventory Related Terms
Aurisco Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:605116 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Aurisco Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurisco Pharmaceutical Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aurisco Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aurisco Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurisco Pharmaceutical Co (SHSE:605116) has a Days Inventory of 328.53 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aurisco Pharmaceutical Co and its competitors. This is 20% above median its historical median of 274.65. Over the past decade, Aurisco Pharmaceutical Co's Days Inventory has ranged from 229.24 to 329.10. According to the industry distribution chart, Aurisco Pharmaceutical Co ranks #452 out of 638 companies in the Biotechnology industry, placing it in the top 70.8%.
Is Aurisco Pharmaceutical Co's Days Inventory too high?
Aurisco Pharmaceutical Co's current Days Inventory of 328.53 is 20% above median its 10-year median of 274.65. Over the past 10 years, this metric has ranged from a low of 229.24 to a high of 329.10. The Biotechnology industry median Days Inventory is 183.20. Aurisco Pharmaceutical Co's value of 328.53 is 79.3% above this industry median. Based on the distribution chart, Aurisco Pharmaceutical Co ranks #452 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Aurisco Pharmaceutical Co has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aurisco Pharmaceutical Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aurisco Pharmaceutical Co ranks #452 out of 638 companies for Days Inventory. This places Aurisco Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 183.20. Aurisco Pharmaceutical Co's value of 328.53 is 79.3% above this benchmark. Historically, Aurisco Pharmaceutical Co's own Days Inventory has ranged from 229.24 to 329.10 over the past decade. While the company's 10-year median is 274.65 vs. the industry median of 183.20, Aurisco Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurisco Pharmaceutical Co's current Days Inventory of 328.53 is 79.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aurisco Pharmaceutical Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurisco Pharmaceutical Co's current Days Inventory is 328.53, which is 20% above median its own 10-year median of 274.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurisco Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Aurisco Pharmaceutical Co (SHSE:605116) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥28.94, compared to a current price of ¥18.74 — trading 35.2% below its estimated fair value. The current Days Inventory is 328.53, which is 20% above median its 10-year median of 274.65 and 79.3% above the Biotechnology industry median of 183.20. Aurisco Pharmaceutical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Aurisco Pharmaceutical Co (SHSE:605116), the current Days Inventory is 328.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurisco Pharmaceutical Co (SHSE:605116) Overvalued in 2026?
Based on GuruFocus' analysis, Aurisco Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥18.74 is trading 35.2% below its estimated GF Value™ of ¥28.94.
GuruFocus considers Aurisco Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:605116:
Days Inventory: 328.53 (20% above median its 10-year median of 274.65)
GF Value™: ¥28.94 vs. price of ¥18.74 (35.2% below fair value)
Industry Position: 79.3% above the Biotechnology median (#452 of 638)
No single metric tells the full story. See the SHSE:605116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.
78GF Score
Get the complete analysis for SHSE:605116
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605116 has been successfully added to your 
